tHEORetically Speaking
Menu Close
  • Home
  • Guest Authors
  • About Us
  • HealthEconomics.Com
  • HE Jobs Portal

Value communication

0

Value Communication is Not Fit for Purpose in Biopharma

Posted on February 12, 2019 by Patti Peeples, R.Ph., Ph.D.

Value communication (VC) is essential for a successful market access strategy that aims to bring interventions to patients. It is no longer enough to simply show that an intervention is effective. VC must also focus on health economics and outcomes… Continue Reading →

Value Communication HEOR, RWE, Value communication

About the HealthEconomics.Com Blog:

Insights, observations, executive interviews, critical analysis, and new research for health economics, outcomes research, real-world evidence, and market access community. We welcome guest bloggers.

Check your inbox or spam folder to confirm your subscription.

Recent Posts

  • How Accelerated Drug Development Requires Disruption in Market Access and Pricing
  • The UK market access has always been complex, now even more than before, Graham Foxon and Paul Craddy?
  • How to Change Clinical Practice Using Health Economics and Outcomes Research
  • Switzerland is strong in many aspects, so also in its health care system, Dr. Peter Indra?

HealthEconomics.Com Twitter Feed

HealthEconomics.Com | A Scientist.com Company Follow

www_healthecon
www_healthecon HealthEconomics.Com | A Scientist.com Company @www_healthecon ·
1h

Pharma Voice Woman of the Week: Miruna Sasu, President and CEO of COTA

http://ow.ly/PK8150KijNZ

#HEOR #RWE #RWD #Pharma #Biotech

Reply on Twitter 1557872227982491648 Retweet on Twitter 1557872227982491648 Like on Twitter 1557872227982491648 Twitter 1557872227982491648
www_healthecon HealthEconomics.Com | A Scientist.com Company @www_healthecon ·
3h

Essential Terms for UK Quality Regulations Post-Brexit

http://ow.ly/QmFb50KihON

#HEOR #Pharma #UK #HTA #Biotech

Reply on Twitter 1557848706380341248 Retweet on Twitter 1557848706380341248 Like on Twitter 1557848706380341248 Twitter 1557848706380341248
www_healthecon HealthEconomics.Com | A Scientist.com Company @www_healthecon ·
5h

Pharma Preps Legal Strategy Against New US Drug Pricing Regulation

http://ow.ly/ITj550Kieg8

#HEOR #Pharma #DrugPrices #Biotech

Reply on Twitter 1557825628900134912 Retweet on Twitter 1557825628900134912 Like on Twitter 1557825628900134912 1 Twitter 1557825628900134912
Load More...

Archives

Visit our website, HealthEconomics.Com, top ranked by Google for news, jobs and resources in healthcare value, market access and more. Read our privacy policy here.
© 2022 tHEORetically Speaking. All rights reserved.
Hiero by aThemes